Patent challenge

0
372

IT has been more than a year since the first compulsory licence was granted to an Indian company manufacturing generic drugs to produce a patented drug. In March 2012, the compulsory licence granted to Natco for manufacturing sorafenib tosylate (brand name Nexavar), a drug whose patent was owned by the pharma giant Bayer Corporation, had significant implications for public health as it promised to make available a life-saving cancer drug at an affordable price.

Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here